ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 134 filers reported holding ANIKA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,777,000 | +23.7% | 77,137 | +20.9% | 0.00% | 0.0% |
| Q3 2016 | $3,053,000 | -11.0% | 63,801 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $3,429,000 | +27.1% | 63,907 | +5.9% | 0.00% | 0.0% |
| Q1 2016 | $2,698,000 | +19.1% | 60,339 | +1.6% | 0.00% | +33.3% |
| Q4 2015 | $2,266,000 | +20.6% | 59,388 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $1,879,000 | -4.5% | 59,036 | -0.9% | 0.00% | +50.0% |
| Q2 2015 | $1,968,000 | -5.5% | 59,590 | +17.8% | 0.00% | -33.3% |
| Q1 2015 | $2,083,000 | +2.5% | 50,596 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $2,032,000 | +10.6% | 49,869 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,838,000 | -17.7% | 50,135 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $2,232,000 | +27.3% | 48,186 | +13.0% | 0.00% | 0.0% |
| Q1 2014 | $1,753,000 | +8.3% | 42,647 | +0.6% | 0.00% | +50.0% |
| Q4 2013 | $1,618,000 | +82.8% | 42,410 | +14.4% | 0.00% | +100.0% |
| Q3 2013 | $885,000 | +44.1% | 37,056 | +2.6% | 0.00% | 0.0% |
| Q2 2013 | $614,000 | – | 36,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |